Drug intelligence / Profile preview

amoxicillin + ampicillin

Development stage
Phase 4
Lead developer
US Antibiotics
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Amoxicillin + ampicillin is a combination of two beta-lactam antibiotics from the penicillin class. Both drugs act by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. Amoxicillin and ampicillin have overlapping but distinct spectra of activity against gram-positive and some gram-negative bacteria. This combination is not a standard or widely marketed formulation; both are typically used individually or in other combinations (e.g., with beta-lactamase inhibitors). The primary indications for each include treatment of infections such as those affecting the respiratory tract, urinary tract, skin, gastrointestinal system, and certain sexually transmitted infections. There is no evidence that this specific combination (amoxicillin + ampicillin) is approved or commonly used as a fixed-dose product.

02

Targets

Beyond the preview

Go deeper on amoxicillin + ampicillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amoxicillin + ampicillin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call